Get startedLog in
    Picture of Sanigen Co logo

    188260 — Sanigen Co Income Statement

    0.000.00%
    kr flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapSucker Stock
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual income statement for Sanigen Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    2025
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:Annual Audited AccountsAnnual Audited AccountsARS/AARS/AAnnual Audited Accounts
    Standards:————
    IFRS
    Status:FinalFinalFinalFinalFinal
    Revenue
    Total Revenue25,22126,75820,18715,42815,354
    Cost of Revenue
    Gross Profit3,6153,8962,8622,4343,109
    Selling / General / Administrative Expenses
    Research And Development
    Depreciation and Amortization
    Unusual Expense / Income
    Total Operating Expenses28,08830,83726,66321,30219,729
    Operating Profit-2,867-4,079-6,477-5,875-4,374
    Gain / Loss on Sale of Assets
    Total Net Non Operating Interest Income / Expense
    Other Net Non Operating Costs
    Net Income Before Taxes-4,281-4,065-9,304-6,547-5,835
    Provision for Income Taxes
    Net Income After Taxes-4,281-4,065-9,246-6,555-5,820
    Net Income Before Extraordinary Items
    Net Income-4,281-4,065-9,246-6,555-5,820
    Income Available to Common Shareholders Excluding Extraordinary Items
    Income Available to Common Shareholders Including Extraordinary Items
    Diluted Net Income-4,281-4,065-9,246-6,555-5,820
    Diluted Weighted Average Shares
    Basic EPS Including Extraordinary Items
    Diluted EPS Including Extraordinary Items
    Diluted EPS Excluding Extraordinary Items
    Normalised Income Before Taxes
    Normalised Income After Taxes
    Normalised Income Available to Common Shareholders
    Diluted Normalised EPS-641-607-1,814-942-819
    Dividends per Share